Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1

Mutation at the R132 residue of IDH1, frequently found in gliomas and acute myelogenous leukemia, creates a neo-enzyme that produces 2-hydroxyglutarate (2-HG) from α-ketoglutarate (α-KG). We sought to therapeutically exploit this neo-reaction in mutant IDH1 cells which requires α-KG derived from glu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Seltzer, Meghan J., Bennett, Bryson D., Joshi, Avadhut D., Gao, Ping, Thomas, Ajit G., Ferraris, Dana V., Tsukamoto, Takashi, Rojas, Camilo J., Slusher, Barbara S., Rabinowitz, Joshua D., Dang, Chi V., Riggins, Gregory J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3058858/
https://ncbi.nlm.nih.gov/pubmed/21045145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-10-1666
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados